Patents by Inventor Eva COLÁS ORTEGA

Eva COLÁS ORTEGA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CTNB1 AS A MARKER FOR ENDOMETRIAL CANCER
    Publication number: 20240011994
    Abstract: Present invention provides a method for diagnosing and prognosing endometrial cancer in easy-to-access isolated samples by detecting the level of expression of one or more proteins. In particular from uterine fluid samples. The invention also provides kits comprising means for detecting said proteins for use in the diagnosis and prognosis of the disease.
    Type: Application
    Filed: June 15, 2023
    Publication date: January 11, 2024
    Inventors: Elena MARTINEZ GARCÍA, Eva COLÁS ORTEGA, Antonio GIL MORENO, Jaume REVENTÓS PUIGJANER, Bruno DOMON, Antoine LESUR, Irene CAMPOY MONCAYO
  • MARKERS OF ENDOMETRIAL CANCER
    Publication number: 20230221323
    Abstract: The present invention provides a method of diagnosis or prognosis endometrial carcinoma, the method comprising determining the level of expression of MMP9 in a uterine aspirate fluid sample from the female genital tract. The present invention further provides kits for the diagnosis of the disease.
    Type: Application
    Filed: November 9, 2022
    Publication date: July 13, 2023
    Inventors: Elena MARTINEZ GARCÍA, Eva COLÁS ORTEGA, Antonio GIL MORENO, Jaume REVENTÓS PUIGJANER, Bruno DOMON, Antoine LESUR
  • CTNB1 AS A MARKER FOR ENDOMETRIAL CANCER
    Publication number: 20200264183
    Abstract: Present invention provides a method for diagnosing and prognosing endometrial cancer in easy-to-access isolated samples by detecting the level of expression of one or more proteins. In particular from uterine fluid samples. The invention also provides kits comprising means for detecting said proteins for use in the diagnosis and prognosis of the disease.
    Type: Application
    Filed: July 20, 2018
    Publication date: August 20, 2020
    Inventors: Elena MARTINEZ GARCÍA, Eva COLÁS ORTEGA, Antonio GIL MORENO, Jaume REVENTÓS PUIGJANER, Bruno DOMON, Antoine LESUR, Irene CAMPOY MONCAYO
  • Markers of Endometrial Cancer
    Publication number: 20190137499
    Abstract: The present invention provides a method of diagnosis or prognosis endometrial carcinoma, the method comprising determining the level of expression of MMP9 in a uterine aspirate fluid sample from the female genital tract. The present invention further provides kits for the diagnosis of the disease.
    Type: Application
    Filed: March 30, 2017
    Publication date: May 9, 2019
    Applicants: FUNDACIÓ HOSPITAL UNIVERSITARI VALL D'H'EBRON-INSTITUT DE RECERCA, LUXEMBOURG INSTITUTE OF HEALTH (LIH), INSTITUT DE RECERCA BIOMÈDICA DE LLEIDA FUNDACIÓ DR. PIFARRÉ
    Inventors: Elena MARTINEZ GARCÍA, Eva COLÁS ORTEGA, Antonio GIL MORENO, Jaume REVENTÓS PUIGJANER, Bruno DOMON, Antoine LESUR